We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Take care when using creams to treat dry skin conditions as they can easily dry onto clothing, bedding and bandages making them more flammable.
Safety leaflet on topical corticosteroids and withdrawal reactions to help patients and their carers to use these medicines safely.
Public health advice for managing cases of non-HCID mpox in prisons and other prescribed places of detention.
How to spot lumpy skin disease, what to do if you suspect it and how to prevent it spreading.
This document outlines guidance for cleaning and decontamination of non-healthcare settings.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Guidance for people who have been diagnosed with a mpox infection and who have been advised to self-isolate at home.
Product Safety Report for Anise Shealight Fading Cream Face & Body (Batch AOS18, 18/06/2023) presenting a serious chemical risk.
Information and guidance on group A streptococcal infections.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).